InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces Participation in Upcoming Emerging Growth Conference

August 16, 2021 10:45:10
RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, will be participating in the Emerging Growth Conference, which is scheduled for Aug. 18, 2021. RYAH CEO Gregory Wagner will be presenting at 9:45 a.m. ET; his presentation is scheduled for 30 minutes and, if time allows, may include a Q&A session. The live, interactive conference is designed to offer existing shareholders and the investment community a chance to better understand RYAH and interact with Wagner in real time. The Emerging Growth conference provides a compelling opportunity for public companies to present information and material about the company and new products and services, as well as any major announcements the companies want to cover. Companies invited to participate in the conference represent a wide range of growth sectors providing diverse and innovative products and services. The conference’s audience could include potentially tens of thousands of individual and institutional investors, as well as investment advisors and analysts. Interested individuals can also view an archived webcast of the RYAH presentation on the conference website. To register for the event, visit https://ibn.fm/FxhE2 To view the full press release, visit https://ibn.fm/7nMpv About RYAH Group Inc. RYAH Group is a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry. Its robust artificial intelligence platform aggregates and correlates HIPAA-compliant patient data, which is intended to help doctors and patients personalize plant-based treatments to better predict treatment outcomes. The data collection is relevant for clinics, doctors, dispensaries and pharmaceutical companies and licensed processors (“LPs”) to monitor and manage formulation effects on patients and demographics. With a strong intellectual property (“IP”) portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle. For more information about the company, please visit www.RyahGroup.com. NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://ibn.fm/RYAH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com [email protected]

InvestorWire is part of the InvestorBrandNetwork.